Ustekinumab in adolescents with recent-onset type 1 diabetes (USTEKID)

Chief Investigator: Prof Colin Dayan

Summary

Trial of a medication, licensed for use in other diseases (Psoriasis, IBD), in people with Type 1 diabetes aged 12-18 and within 100 days of diagnosis.

See this video on the T!D site

Further details can be found at the T1D consortium page here


Contact Details

Trial Manager / Lead Contact: Dr Kym Carter
Phone: 01792606372
Email: k.carter@swansea.ac.uk

Website: https://www.swansea.ac.uk/staff/medicine-health-life-science/medicine/health-data-science/carter-k/
Twitter: https://twitter.com/kymberleycarter

ISCRTN Number: 14274380 ;